Summary
Bristol-Myers Squibb Company (BMY) filed a Current Report on Form 8-K on November 27, 2006, primarily to disclose the submission of XBRL-formatted financial data. This filing includes documents from their quarterly report for the period ending September 30, 2006, presented in XBRL format. The company explicitly states that this XBRL data is unaudited and intended for testing the XBRL format and related technology, not as official financial statements. Investors are strongly advised to rely on the officially filed versions of financial documents and not to use this XBRL-formatted data for investment decisions. The filing emphasizes that this information is not deemed "filed" under Section 18 of the Exchange Act and will not be incorporated by reference into other filings, underscoring its experimental and informational nature.
Key Highlights
- 1BMY filed an 8-K on November 27, 2006, reporting events on November 2, 2006.
- 2The primary purpose of the filing is to provide XBRL-formatted financial data from the Q3 2006 10-Q.
- 3The XBRL data is explicitly stated as unaudited.
- 4This XBRL submission is for testing the XBRL format and technology.
- 5Investors should rely on the official filed financial statements, not this XBRL data, for investment decisions.
- 6The XBRL information is not considered 'filed' for liability purposes under Section 18 of the Exchange Act.
- 7The filing includes various XBRL documents such as instance, schema, calculation, label, and presentation linkbase documents.